Washington — The antidepressant Paxil may raise the risk of suicidal behavior in young adults, GlaxoSmithKline and the Food and Drug Administration warned Friday in a letter to doctors.
The warning letter was accompanied by changes to the labeling of both Paxil and Paxil CR, a controlled-release version of the drug, also called paroxetine.
A recent analysis of clinical trial data on nearly 15,000 patients treated with both Paxil and dummy pills revealed a higher frequency of suicidal behavior in young adults treated with the drug, according to the letter.
The FDA reported that there were 11 suicide attempts - none resulting in death - among the patients given Paxil in the trials. Just one of the dummy pill patients attempted suicide.
Comments
LJWorld.com doesn’t necessarily condone the comments here, nor does it review every post. Read our full policy. Also, read about banned accounts and harassing comments.
Ragingbear (anonymous) says…
DUH! I could have told you this. I became suicidal when I was on this stuff, as well as some other family members of mine.
Of course, the Doctors today just prescribe this stuff, and act like your cured. When you go back saying that it isn't working, or that you are feeling worse, they say you just need to take more of it.